Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type (Small Molecule, Large Molecule)

Published Date: September 2020 | Report Code : HC2068897


Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type (Small Molecule, Large Molecule), By Technology(Machine Learning(Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning), and Other Technology), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, and Others), By End User(Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) – Market Size & Forecasting to 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2068897

Status : Published September 2020

The global artificial intelligence (AI) in drug discovery market is expected to reach USD XX million by 2028, at a CAGR of XX from USD XX million in 2020. In the drug discovery industry, artificial Intelligence uses a complex method of recognition that prevents conventional clinical trials and errors. Particular tasks are performed with the aid of artificial intelligence that include enhanced ability to produce, understand and interpret speech and text through natural language processing, and the use of artificial neural networks to simulate the brain.

In the drug discovery market, the use of artificial intelligence is propelled by the development of advanced algorithms, the availability of large data sets, and increased computer processing power. The growth of artificial intelligence drug discovery market is mainly driven by factors such as the growing numbers of patients suffering from chronic diseases and a thriving healthcare industry, coupled with the manufacturers' approach to lower drug production costs.

Moreover, investments by major players in the bio-pharmaceutical sector, as well as increasing public and private collaborations for R&D activities, are expected to fuel the target market development. However, limited availability of data sets in the drug discovery field and the unavailability of skilled labor are a few challenges for the market growth.

Historic background for the artificial intelligence (AI) in drug discovery market has been analyzed according to the latest developments to provide precise market size estimations. Also, the key factors that are impacting the growth of the artificial intelligence (AI) in drug discovery market have been identified with potential gravity. Major regions covered in the study include North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World.

Regional Outlook:

On the basis of geography, the worldwide artificial intelligence (AI) in drug discovery market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa and South America. North America is predicted to hold a dominant position because this region has been an early adopter of AI technology in drug discovery and development.

In addition, the presence of major key players in the region is expected to boost the market growth in the region. Emerging economies also are projected to witness significant growth in the market over the forecast period. In order to promote advanced devices for R&D operations, the Asia Pacific market is expected to experience faster growth due to increased government spending on improving the present healthcare infrastructure.

Growing awareness about AI among pharmaceutical companies is another factor that is expected to promote the growth of the target market in this area. Other regions like Middle East & Africa and Latin America are expected to be lucrative markets for artificial intelligence (AI) in drug discovery in the near future due to the high rate of adoption of AI system and the rapid expansion of the healthcare industry in these regions.

Competitive Landscape

The competitive scenario highlights the performance of major companies operating in the artificial intelligence (AI) in drug discovery market. This includes the detailed profiling of major companies and their competitive benchmarking. Product profiling provides key information including products/solutions offered, key developments, company performances, and strategies adopted in recent years.

The major companies profiled in the market include ATOMWISE, INC., Insilico Medicine, Inc., BIOAGE, Numerate, Inc., NuMedii, Inc., Envisagenics, Cloud Pharmaceuticals, Inc., Benevolent AI, Exscientia, TwoXAR Incorporated, Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Google, and Berg LLC, among others.

The competitive landscape provides a detailed description of each company, including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

What Does This Report Provide?

This report provides a detailed understanding of the global artificial intelligence in drug discovery market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Drug Type

  • Small Molecule
  • Large Molecules

By Technology

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Technologies

By Therapeutic Type

  • Metabolic Disease
  • Cardiovascular Disease
  • Oncology
  • Neurodegenerative Diseases
  • Others

By End User

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Drug type
    • By Technology
    • By Therapeutic Type
    • By End User
  • Europe
    • By Country (Russia, Germany, UK, France, Italy, Spain, The Netherlands, Rest of Europe)
    • By Drug type
    • By Technology
    • By Therapeutic Type
    • By End User
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Drug type
    • By Technology
    • By Therapeutic Type
    • By End User
  • Middle East and Africa
    • By Country (UAE, Saudi Arabia, Qatar, Turkey, South Africa, Rest of Middle East and Africa)
    • By Drug type
    • By Technology
    • By Therapeutic Type
    • By End User
  • South America
    • By Country (Argentina, Brazil, Rest of South America)
    • By Drug type
    • By Technology
    • By Therapeutic Type
    • By End User

Reasons to Buy This Report:

  • Market size estimation of the artificial intelligence (AI) in drug discovery market on a regional and global basis
  • Unique research usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments, helping every stakeholder in the market
  • COVID-19 impact analysis on artificial intelligence (AI) in drug discovery market 


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy